Coronavirus disease-19 and cardiovascular disease: A risk factor or a risk marker?

被引:8
作者
Liu, Jing [1 ]
Virani, Salim S. [1 ,2 ]
Alam, Mahboob [1 ]
Denktas, Ali E. [1 ]
Hamzeh, Ihab [1 ]
Khalid, Umair [1 ,2 ]
机构
[1] Baylor Coll Med, Dept Med, Cardiol Sect, Houston, TX 77030 USA
[2] Michael E DeBakey VA Med Ctr, Dept Med, Cardiol Sect, Houston, TX USA
关键词
cardiovascular diseases; complications; COVID-19; ACUTE MYOCARDIAL-INFARCTION; COVID-19; PREVALENCE; PATIENT; ACE2;
D O I
10.1002/rmv.2172
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Severe acute respiratory syndrome coronavirus-2 causes the clinical syndrome of coronavirus disease of 2019 (COVID-19) which has become a global pandemic resulting in significant morbidity and mortality. While the virus primarily affects the respiratory system, it also causes a wide variety of complex cardiac manifestations such as acute myopericarditis, acute coronary syndrome, congested heart failure, cardiogenic shock and cardiac arrhythmias. There are numerous proposed mechanisms of cardiac injury, including direct cellular injury, pro-inflammatory cytokine storm, myocardial oxygen-demand mismatch, and systemic inflammation causing multi-organ failure. Additionally, medications commonly used to treat COVID-19 patients have various cardiovascular side effects. We aim to provide a succinct review about the pathophysiology and cardiac manifestations of COVID-19, as well as treatment considerations and the various adaptations made to the current healthcare structure as a result of the pandemic.
引用
收藏
页数:9
相关论文
共 77 条
[1]   COVID-19 and the Heart [J].
Akhmerov, Akbarshakh ;
Marban, Eduardo .
CIRCULATION RESEARCH, 2020, 126 (10) :1443-1455
[2]  
[Anonymous], INTENS CARE MED 0311, DOI DOI 10.1007/S15010-020-01473-W
[3]   Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State [J].
Arentz, Matt ;
Yim, Eric ;
Klaff, Lindy ;
Lokhandwala, Sharukh ;
Riedo, Francis X. ;
Chong, Maria ;
Lee, Melissa .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (16) :1612-1614
[4]   ST-Segment Elevation in Patients with Covid-19-A Case Series [J].
Bangalore, Sripal ;
Sharma, Atul ;
Slotwiner, Alexander .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (25) :2478-2480
[5]   Cardiovascular disease and COVID-19 [J].
Bansal, Manish .
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (03) :247-250
[6]   ISTH interim guidance on recognition and management of coagulopathy in COVID-19: A comment [J].
Barrett, Christopher D. ;
Moore, Hunter B. ;
Yaffe, Michael B. ;
Moore, Ernest E. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (08) :2060-2063
[7]   Acute myocarditis associated with COVID-19 infection [J].
Besler, Muhammed Said ;
Arslan, Halil .
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2020, 38 (11) :2489.e1-2489.e2
[8]   Acute Myocarditis With Ventricular Noncompaction in a COVID-19 Patient [J].
Bonnet, Marc ;
Craighero, Fabien ;
Harbaoui, Brahim .
JACC-HEART FAILURE, 2020, 8 (07) :599-600
[9]  
Bozkurt B, 2020, HFSA ACC AHA STATEME
[10]   Cardiac toxicity secondary to long term treatment with chloroquine [J].
Cervera, A ;
Espinosa, G ;
Cervera, R ;
Font, J ;
Ingelmo, M .
ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (03) :301-301